Related Experiment Videos
[New psychotropic drugs - "legal highs"]
N Scherbaum1, F Schifano2, H Siemann1
1Klinik für abhängiges Verhalten und Suchtmedizin, LVR-Klinikum Essen, Kliniken der Universität Duisburg-Essen.
Fortschritte Der Neurologie-Psychiatrie
|September 2, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective.
Progress in neuro-psychopharmacology & biological psychiatry·2024
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2024
Stimulant and hallucinogenic novel psychoactive substances; an update.
Expert review of clinical pharmacology·2023
A Pan-European Review of Good Practices in Early Intervention Safeguarding Practice with Children, Young People and Families: Evidence Gathering to Inform a Multi-disciplinary Training Programme (the ERICA Project) in Preventing Child Abuse and Neglect in Seven European Countries.
International journal on child maltreatment : research, policy and practice·2022
[Memory distortions in Alzheimer's disease and other dementias: an underestimated diagnostic parameter].
Fortschritte der Neurologie-Psychiatrie·2026
[Multiple system atrophy].
Fortschritte der Neurologie-Psychiatrie·2026
[Predicting and Preventing Alzheimer's Disease].
Fortschritte der Neurologie-Psychiatrie·2026
[Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis].
Fortschritte der Neurologie-Psychiatrie·2026
Evaluating the relationship of exposure to adverse childhood experiences and pain in healthy subjects.
Fortschritte der Neurologie-Psychiatrie·2026
[Rare hereditary and acquired diseases with parkinson's syndrome].
Fortschritte der Neurologie-Psychiatrie·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026
Pharmacogenomic and Medicinal Chemistry Perspectives on Off-label Drug Use.
Mini reviews in medicinal chemistry·2026
A SHAP-Informed Formal Feature Attribution Framework for Drug-Drug Interaction Risk in Large-Scale Claims Data.
Clinical and translational science·2026
Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment - a scoping review.
The International journal on drug policy·2026
US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.
The Journal of pharmacology and experimental therapeutics·2026
Examining Increased Ritalin and Adderall Use Among Low-Income People Who Use Drugs: Mixed Methods Study.
JMIR formative research·2026